Among STAT family members, STAT3 is the most well-studied member; it is overexpressed in the majority of human cancers, and targeting STAT3 signaling has been recognized as a potential strategy for treating cancer owing to its roles in tumor formation, metastasis, and drug resistance [9, 10]. This evidence concerns the gene SOAT1 and cancer.